Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 10:28 PM
Study NCT ID:
NCT05586958
Status:
COMPLETED
Last Update Posted:
2025-10-29
First Post:
2022-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Sponsor:
LG Chem
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-25
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-16
Completion Date Type:
ACTUAL
First Submit Date:
2022-10-16
First Submit QC Date:
None
Study First Post Date:
2022-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-07-14
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-27
Last Update Post Date:
2025-10-29
Last Update Post Date Type:
ESTIMATED